BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24903451)

  • 1. Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.
    Gupta AK; Nakrieko KA
    Br J Dermatol; 2015 Jan; 172(1):74-80. PubMed ID: 24903451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine.
    Zaias N; Rebell G
    Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
    de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
    Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
    Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in restriction fragment length polymorphisms among serial isolates from patients with Trichophyton rubrum infection.
    Gupta AK; Kohli Y; Summerbell RC
    J Clin Microbiol; 2001 Sep; 39(9):3260-6. PubMed ID: 11526160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichophyton rubrum DNA Strains in Patients with Onychomycosis with Persistent Mixed Infections Involving a Nondermatophyte Mold.
    Gupta AK; Nakrieko KA
    J Am Podiatr Med Assoc; 2020 Nov; 110(6):. PubMed ID: 32810210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies.
    Mulvaney PM; Telang GH; Jellinek N
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine.
    Zaias N; Serrano L
    Clin Exp Dermatol; 1989 Mar; 14(2):120-3. PubMed ID: 2532084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of superficial white onychomycosis with topical terbinafine cream.
    Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Sep; 141(3):604-5. PubMed ID: 10583101
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular strain typing of Trichophyton rubrum indicates multiple strain involvement in onychomycosis.
    Yazdanparast A; Jackson CJ; Barton RC; Evans EG
    Br J Dermatol; 2003 Jan; 148(1):51-4. PubMed ID: 12534594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: onychomycosis due to Trichophyton schoenleinii.
    Macura AB; Krzyściak P; Skóra M; Gniadek A
    Mycoses; 2012 Mar; 55(2):e18-9. PubMed ID: 21771109
    [No Abstract]   [Full Text] [Related]  

  • 18. Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay.
    Gupta AK; Zaman M; Singh J
    Br J Dermatol; 2007 Oct; 157(4):698-703. PubMed ID: 17714569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
    Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
    An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis: rationalization of topical treatment.
    Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
    Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.